Cargando…

Targeted Metabolomics Analysis of Bile Acids in Patients with Idiosyncratic Drug-Induced Liver Injury

Drug-induced liver injury (DILI) is rare but clinically important due to a high rate of mortality. However, specific biomarkers for diagnosing and predicting the severity and prognosis of DILI are lacking. Here, we used targeted metabolomics to identify and quantify specific types of bile acids that...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xie, Zhongyang, Zhang, Lingjian, Chen, Ermei, Lu, Juan, Xiao, Lanlan, Liu, Qiuhong, Zhu, Danhua, Zhang, Fen, Xu, Xiaowei, Li, Lanjuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8706581/ https://www.ncbi.nlm.nih.gov/pubmed/34940610 http://dx.doi.org/10.3390/metabo11120852

Ejemplares similares

Serum CXCL1 Is a Prognostic Factor for Patients With Hepatitis B Virus–Related Acute-On-Chronic Liver Failure
por: Xiao, Lanlan, et al.
Publicado: (2021)

Metabolomic Analysis of Pediatric Patients with Idiosyncratic Drug-Induced Liver Injury According to the Updated RUCAM
por: Andújar-Vera, Francisco, et al.
Publicado: (2023)

Immune mechanisms of idiosyncratic drug-induced liver injury
por: Mak, Alastair, et al.
Publicado: (2017)

Low Growth Hormone Levels Predict Poor Outcome of Hepatitis B Virus-Related Acute-on-Chronic Liver Failure
por: Wu, Daxian, et al.
Publicado: (2021)

Update on Advances in Research on Idiosyncratic Drug-Induced Liver Injury
por: Kim, Seung-Hyun, et al.
Publicado: (2016)

Idiosyncratic drug‐induced liver injury: A short review
por: Yamashita, Yo‐ichi, et al.
Publicado: (2017)

Treatment of Idiosyncratic Drug-Induced Liver Injury Using Steroids
por: Sundaram, Suneha, et al.
Publicado: (2020)

Idiosyncratic Drug-Induced Liver Injury: Mechanistic and Clinical Challenges
por: Jee, Alison, et al.
Publicado: (2021)

Idiosyncratic Liver Injury Due to Levocetirizine
por: Annunziata, Giuseppe, et al.
Publicado: (2019)

1,5-Anhydroglucitol Predicts Mortality in Patients with HBV-Related Acute-on-chronic Liver Failure
por: Zhang, Lingjian, et al.
Publicado: (2022)

Characterization of an Artificial Liver Support System-Related Vasovagal Reaction
por: Ma, Shanshan, et al.
Publicado: (2020)

Artificial liver support system therapy in acute-on-chronic hepatitis B liver failure: Classification and regression tree analysis
por: Huang, Kaizhou, et al.
Publicado: (2019)

Stem Cell Strategies to Evaluate Idiosyncratic Drug-induced Liver Injury
por: Krueger, Winfried, et al.
Publicado: (2014)

Identification of a Potential miRNA–mRNA Regulatory Network Associated With the Prognosis of HBV-ACLF
por: Ma, Shanshan, et al.
Publicado: (2021)

Corrigendum: Identification of a Potential miRNA-mRNA Regulatory Network Associated With the Prognosis of HBV-ACLF
por: Ma, Shanshan, et al.
Publicado: (2021)

A prognostic model for hepatitis B acute‐on‐chronic liver failure patients treated using a plasma exchange‐centered liver support system
por: Xie, Zhongyang, et al.
Publicado: (2019)

Role of Ursodeoxycholic Acid in Treating and Preventing Idiosyncratic Drug-Induced Liver Injury. A Systematic Review
por: Robles-Díaz, Mercedes, et al.
Publicado: (2021)

Idiosyncratic Drug-Induced Liver Injury (IDILI): Potential Mechanisms and Predictive Assays
por: Roth, Alexander D., et al.
Publicado: (2017)

Metamizole: An underrated agent causing severe idiosyncratic drug‐induced liver injury
por: Sebode, Marcial, et al.
Publicado: (2020)

Mechanism of idiosyncratic drug induced liver injury (DILI): unresolved basic issues
por: Teschke, Rolf, et al.
Publicado: (2021)

Oral cladribine treatment and idiosyncratic drug-induced liver injury in multiple sclerosis
por: Rakers, Florian, et al.
Publicado: (2023)

Comprehensive immune cell analysis of human menstrual-blood-derived stem cells therapy to concanavalin A hepatitis
por: Zhang, Fen, et al.
Publicado: (2022)

Customised in vitro model to detect human metabolism-dependent idiosyncratic drug-induced liver injury
por: Tolosa, Laia, et al.
Publicado: (2017)

An electronic medical records-based approach to identify idiosyncratic drug-induced liver injury in children
por: Sandritter, Tracy L., et al.
Publicado: (2019)

Preclinical models of idiosyncratic drug-induced liver injury (iDILI): Moving towards prediction
por: Segovia-Zafra, Antonio, et al.
Publicado: (2021)

Idiosyncratic drug-induced liver injury caused by givosiran in a patient with acute intermittent porphyria
por: Ma, Christopher D., et al.
Publicado: (2022)

Plasma Sphingoid Base Profiles of Patients Diagnosed with Intrinsic or Idiosyncratic Drug-induced Liver Injury
por: Gai, Zhibo, et al.
Publicado: (2023)

Poria Attenuates Idiosyncratic Liver Injury Induced by Polygoni Multiflori Radix Praeparata
por: Gao, Dan, et al.
Publicado: (2016)

Metabolomic Study on Idiosyncratic Liver Injury Induced by Different Extracts of Polygonum multiflorum in Rats Integrated with Pattern Recognition and Enriched Pathways Analysis
por: Li, Chun-Yu, et al.
Publicado: (2016)

Knockdown of CXCL1 improves ACLF by reducing neutrophil recruitment to attenuate ROS production and hepatocyte apoptosis
por: Tang, Shima, et al.
Publicado: (2023)

A New Fluidized Bed Bioreactor Based on Diversion-Type Microcapsule Suspension for Bioartificial Liver Systems
por: Lu, Juan, et al.
Publicado: (2016)

The Application of Mesenchymal Stem Cells in the Treatment of Liver Diseases: Mechanism, Efficacy, and Safety Issues
por: Yang, Ya, et al.
Publicado: (2021)

Serum metabolome and targeted bile acid profiling reveals potential novel biomarkers for drug-induced liver injury
por: Ma, Zhenhua, et al.
Publicado: (2019)

Idiosyncratic Drug-Induced Liver Injury Due to Ciprofloxacin: A Report of Two Cases and Review of the Literature
por: Radovanovic, Milan, et al.
Publicado: (2018)

Mesenchymal stem cell-based cell-free strategies: safe and effective treatments for liver injury
por: Hu, Chenxia, et al.
Publicado: (2020)

Molecular Idiosyncratic Toxicology of Drugs in the Human Liver Compared with Animals: Basic Considerations
por: Teschke, Rolf
Publicado: (2023)

Idiosyncratic Drug Induced Liver Injury, Cytochrome P450, Metabolic Risk Factors and Lipophilicity: Highlights and Controversies
por: Teschke, Rolf, et al.
Publicado: (2021)

Therapeutic Management of Idiosyncratic Drug-Induced Liver Injury and Acetaminophen Hepatotoxicity in the Paediatric Population: A Systematic Review
por: Niu, Hao, et al.
Publicado: (2022)

Intrahepatic infiltration of activated CD8(+) T cells and mononuclear phagocyte is associated with idiosyncratic drug-induced liver injury
por: Yang, Hyun, et al.
Publicado: (2023)

8. Myositis as an idiosyncratic drug reaction to leflunomide
por: Darren, Angeline, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_jg76ko03qc18llniq4l432plpk